GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung ...
It was formed when two companies merged in the early 2000s. GSK is involved in creating medicines, vaccines, and health products, and it has a strong presence in North Carolina, especially in the ...
GlaxoSmithKline (GSK) is to collaborate with the Francis Crick Institute, a new powerhouse of academic- and charity-funded biomedical research based in London. The new partnership is expected to ...
That fact was brought into stark focus again in early December when UK-based GSK announced plans to lay off 900 of its 2,500 R&D people in RTP. The huge global company has about 4,300 Triangle area ...
One of the most important things to know when playing online slots is the RTP (Return to Player) percentage of each game you play. Not every slot is created equal, and a big reason is that they ...
Check Out Our Latest Report on GSK GSK Stock Down 1.1 % GSK opened at $38.54 on Friday. The firm has a 50 day moving average price of $41.44 and a 200 day moving average price of $41.26. The ...
London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. The Big Pharma is joining forces with researchers from the Center for Regenerative ...
Norwich Research Park is a globally-known centre for science research excellence among the science community, but now Anglia Innovation Partnership, the organisation that manages the park campus ...
GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...